Physician profile
Joshua Stone
NPI 1477782266
$2,315.98
in general payments reported to CMS, 2019-2025
7 companies · $180 in 2025
The $180 reported for 2025 was more than what a typical Oral and Maxillofacial Surgery provider received nationally (typical 2025 total: $150).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $409 · 2020: $176 · 2021: $351 · 2022: $129 · 2023: $591 · 2024: $479 · 2025: $180.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,251.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,250.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kls-Martin L.P. | $696.31 | 2019-2023 | |
| Depuy Synthes Sales INC. | $617.25 | 2021-2025 | Trumatch, Matrixorthognathic, Matrixmidface |
| Stryker Corporation | $340.90 | 2019-2024 | Vsp System, Vsp Cranial, Patient-Fitted Tmj Reconstructive Prosthesis System, Na |
| Axogen | $312.02 | 2019-2025 | Axoguard Nerve Connector, Avance Nerve Graft, Axoguard Nerve Cap |
| Abbvie INC. | $211.95 | 2021 | |
| Zimmer Biomet Holdings, INC. | $120.88 | 2019-2023 | Traumaone |
| Straumann USA LLC | $16.67 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joshua Stone listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.